| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.21 Billion | USD 7.51 Billion | 4.08% | 2025 |
FrequentlyAsked Questions
Amoxicillin is a popular penicillin antibiotic. It is used for treating bacterial infections.
The global amoxicillin market is expected to be driven by rising cases of bacterial infections.
According to study, the global amoxicillin market size was worth around USD 5.21 billion in 2025 and is predicted to grow to around USD 7.51 billion by 2034.
The CAGR value of the amoxicillin market is expected to be around 4.08% during 2026-2034.
The global amoxicillin industry is anticipated to be challenged by the rising cases of counterfeit drugs.
The retail pharmacy segment holds the largest market share in the amoxicillin market.
The global amoxicillin market has performed well so far and will offer similar trends in the coming years.
North America will contribute notably towards the amoxicillin market value.
The global amoxicillin market is led by players like Sun Pharmaceutical Industries, Aurobindo Pharma, CSPC Pharmaceutical Group, GlaxoSmithKline (GSK), North China Pharmaceutical Group Corporation (NCPC), Cipla, Meiji Holdings, Centrient Pharmaceuticals, Teva Pharmaceuticals, Novartis, Viatris, Guangzhou Baiyunshan Pharmaceutical Holdings, Sandoz, Hikma Pharmaceuticals, and Dr. Reddy's Laboratories.
The report explores crucial aspects of the amoxicillin market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients